Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT1 | P30419 | 7/20 | 0.51 |
| ▸ | NMT2 | O60551 | 6/20 | 0.51 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | FURIN | P09958 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.38 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14669744 | 0.91 | NMT2 (0.50) | NMT1NMT2FURINSIRT6SIRT1 | |
| SCHEMBL29630443 | 0.87 | NMT1 (0.51) | NMT1NMT2TLR2FOLH1CPB2 | |
| SCHEMBL14669796 | 0.85 | NMT2 (0.38) | NMT1NMT2FOLH1FURINCPB2 | |
| SCHEMBL20529374 | 0.85 | NMT2 (0.43) | NMT1NMT2FOLH1FURINCPB2 | |
| SCHEMBL29591503 | 0.85 | NMT1 (0.49) | NMT1NMT2TLR2FOLH1FURIN | |
| SCHEMBL30436706 | 0.85 | NMT1 (0.52) | NMT1NMT2TLR2FOLH1FURIN | |
| SCHEMBL30781971 | 0.84 | NMT1 (0.48) | NMT1NMT2TLR2FOLH1FURIN | |
| SCHEMBL31408939 | 0.84 | GSR (0.47) | NMT1NMT2FOLH1FURINCPB2 | |
| SCHEMBL31188429 | 0.84 | GSR (0.47) | NMT1NMT2TLR2FOLH1CPB2 | |
| SCHEMBL29564895 | 0.84 | SLC15A2 (0.49) | NMT1NMT2FOLH1FURINCPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130029920-A1 | Metal Nanoparticles | BRIMBLE MARGARET A (NZ) | 2013-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130029920-A1 | Metal Nanoparticles | PSTPIP2, PCNP, ANPEP | NMT1 395/4885NMT2 613/4885TLR2 4535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.